The potential effect of semaglutide on taste perception and recognition needs further exploration in more diverse clinical groups (180)
In the first 72 weeks of the study, all doses tested led to meaningful weight loss, ranging from patients losing 7.8% of their body weight at the lowest dose to 12.4% at the highest dose, with the placebo group seeing little to no weight changes. Since the trial is double-blinded, Rasouli doesnt know if Swaney is one of the 30% of patients receiving the placebo
Some researchers question whether such extended holds make sense, since GLP-1RAs delay gastric emptying of solids by just 36 minutes [34]
They actually address the specific concern, which is rare in this space
Medicare and Medicaid: Medicare Part D has historically not covered compounded medications
However, in this case, there are numerous obstacles to cross, mainly financial and resource barriers, intellectual properties, data access barriers, biases, and liability risks (Masuda et al., 2020)